HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis.

Abstract
The objective of the study is to verify effects of nebulized 3% saline hypertonic solution (HS) in comparison to normal saline (NS) in addition to epinephrine in hospitalized children with bronchiolitis. Infants were randomly assigned either to receive every 6 hours nebulized NS (group I) or 3% HS (group II) in addition to epinephrine (1.5 mg) and to conventional treatment. The main endpoints of this study were the length of stay (LOS) in hospital and the clinical response score (CSS). Patients presented a significant decrease in CSS from the first through the third day of treatment, present in the first group but even more evident in the second group (p=0.0001). Comparison between group I and II data shows significant decrease in CSS in the 3% HS-treated patients both at the second (p<0.005) and at the third day of treatment (p<0.005). Infants in the NS control group had a mean LOS of 5.6±1.6 days, whereas children treated with 3% HS were discharged with a LOS of 4.9±1.3 days, reaching a significant decrease in stay (p<0.05). In hospitalized patients bronchiolitis nebulized 3% HS and epinephrine significantly decreased symptoms and LOS as compared to 0.9% NS and epinephrine.
AuthorsM Miraglia Del Giudice, F Saitta, S Leonardi, M Capasso, B Niglio, I Chinellato, F Decimo, N Maiello, C Capristo, L Perrone, D Peroni
JournalInternational journal of immunopathology and pharmacology (Int J Immunopathol Pharmacol) 2012 Apr-Jun Vol. 25 Issue 2 Pg. 485-91 ISSN: 0394-6320 [Print] England
PMID22697080 (Publication Type: Letter, Randomized Controlled Trial)
Chemical References
  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Saline Solution, Hypertonic
  • Epinephrine
Topics
  • Administration, Inhalation
  • Adrenergic beta-Agonists (administration & dosage, adverse effects)
  • Age Factors
  • Bronchiolitis (diagnosis, drug therapy)
  • Bronchodilator Agents (administration & dosage, adverse effects)
  • Epinephrine (administration & dosage, adverse effects)
  • Female
  • Hospitalization
  • Humans
  • Infant
  • Italy
  • Length of Stay
  • Linear Models
  • Male
  • Nebulizers and Vaporizers
  • Saline Solution, Hypertonic (administration & dosage, adverse effects)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: